247 related articles for article (PubMed ID: 21129329)
1. Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.
Farhy LS; McCall AL
J Diabetes Sci Technol; 2010 Nov; 4(6):1345-56. PubMed ID: 21129329
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic network control of glucagon secretion and counterregulation.
Farhy LS; McCall AL
Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
[TBL] [Abstract][Full Text] [Related]
3. System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.
Farhy LS; McCall AL
J Diabetes Sci Technol; 2009 Jan; 3(1):21-33. PubMed ID: 20046648
[TBL] [Abstract][Full Text] [Related]
4. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
Farhy LS; McCall AL
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
[TBL] [Abstract][Full Text] [Related]
5. Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.
Farhy LS; Du Z; Zeng Q; Veldhuis PP; Johnson ML; Brayman KL; McCall AL
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E575-85. PubMed ID: 18577688
[TBL] [Abstract][Full Text] [Related]
6. Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.
Farhy LS; Chan A; Breton MD; Anderson SM; Kovatchev BP; McCall AL
Front Physiol; 2012; 3():40. PubMed ID: 22403550
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
8. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
Cryer PE
Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
[TBL] [Abstract][Full Text] [Related]
9. The physiology of glucagon.
Taborsky GJ
J Diabetes Sci Technol; 2010 Nov; 4(6):1338-44. PubMed ID: 21129328
[TBL] [Abstract][Full Text] [Related]
10. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells].
Collombat P; Mansouri A
Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395
[No Abstract] [Full Text] [Related]
11. Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.
Bethea M; Bozadjieva-Kramer N; Sandoval DA
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34318874
[TBL] [Abstract][Full Text] [Related]
12. Design principles of the paradoxical feedback between pancreatic alpha and beta cells.
Garzilli I; Itzkovitz S
Sci Rep; 2018 Jul; 8(1):10694. PubMed ID: 30013127
[TBL] [Abstract][Full Text] [Related]
13. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
14. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
Gilon P
J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
[TBL] [Abstract][Full Text] [Related]
15. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
Cryer PE; Gerich JE
N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
[TBL] [Abstract][Full Text] [Related]
16. Translational aspects of glucagon: current use and future prospects.
Kaur J; Seaquist ER
J Endocrinol; 2023 Apr; 257(1):. PubMed ID: 36727600
[TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
18. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.
Gromada J; Franklin I; Wollheim CB
Endocr Rev; 2007 Feb; 28(1):84-116. PubMed ID: 17261637
[TBL] [Abstract][Full Text] [Related]
19. Conflicting Views About Interactions Between Pancreatic α-Cells and β-Cells.
Weir GC; Bonner-Weir S
Diabetes; 2023 Dec; 72(12):1741-1747. PubMed ID: 37983524
[TBL] [Abstract][Full Text] [Related]
20. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
